Cargando…

A Longitudinal Comparison of the Recovery Patterns of Optic Neuritis with MOG Antibody-Seropositive and AQP4 Antibody-Seropositive or -Seronegative for Both Antibodies

In this study, the aim is to compare the recovery pattern among patients with acute myelin oligodendrocyte glycoprotein antibody-seropositive optic neuritis (MOG-Ab + ON) attacks and aquaporin-4 antibody-seropositive ON (AQP4-Ab + ON) or -seronegative ON. At the onset of the first-ever ON attack, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Lin, Tan, Xiao, Wang, Ling, Zhao, Xiujuan, Qiu, Wei, Yang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964224/ https://www.ncbi.nlm.nih.gov/pubmed/35360549 http://dx.doi.org/10.1155/2022/4951491

Ejemplares similares

Structural and Functional Alterations in Visual Pathway After Optic Neuritis in MOG Antibody Disease: A Comparative Study With AQP4 Seropositive NMOSD
por: Gao, Chenyang, et al.
Publicado: (2021)

Pattern Visually Evoked Potentials in Japanese Girl With Optic Neuritis and Seropositive to Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Takano, Shunichiro, et al.
Publicado: (2019)

Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS
por: Duan, Yunyun, et al.
Publicado: (2021)

Prevalence of serum MOG antibody and AQP4 antibody in optic neuritis after SARS-CoV-2 infection
por: Sun, Chuan-bin
Publicado: (2023)

MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome
por: Mariotto, Sara, et al.
Publicado: (2017)

Microstructural visual system changes in AQP4-antibody–seropositive NMOSD
por: Oertel, Frederike C., et al.
Publicado: (2017)

Factors influencing intravenous methylprednisolone pulse therapy in Chinese patients with isolated optic neuritis associated with AQP4 antibody-seropositive neuromyelitis optica
por: Guo, Sitong, et al.
Publicado: (2021)

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients
por: Pache, Florence, et al.
Publicado: (2016)

Association of aquaporin-4 antibody-seropositive optic neuritis with vision-related quality of life and depression
por: Song, Ruitong, et al.
Publicado: (2023)

Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood
por: Chen, Xuelian, et al.
Publicado: (2023)

Clinical, radiological, therapeutic and prognostic differences between MOG-seropositive and MOG-seronegative pediatric acute disseminated encephalomyelitis patients: a retrospective cohort study
por: Dong, Xueshan, et al.
Publicado: (2023)

Different Characteristics of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Seropositive Male Optic Neuritis in China
por: Song, Honglu, et al.
Publicado: (2019)

Corrigendum: Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood
por: Chen, Xuelian, et al.
Publicado: (2023)

Isolated Double-Positive Optic Neuritis: A Case of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody Seropositivity
por: Mason, Matthew C, et al.
Publicado: (2021)

Optic Neuritis in a Patient with Seropositive Myelin Oligodendrocyte Glycoprotein Antibody During the Post-COVID-19 Period
por: Žorić, Lepša, et al.
Publicado: (2021)

Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis
por: Chalmoukou, Konstantina, et al.
Publicado: (2015)

Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis
por: Mori, Sotaro, et al.
Publicado: (2020)

Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders
por: Oertel, Frederike Cosima, et al.
Publicado: (2023)

Seropositivity of Dengue Antibodies during Pregnancy
por: Mohamed Ismail, Nor Azlin, et al.
Publicado: (2014)

Transient Tunnel Vision as Initial Presentation of Anti-MOG Antibody Positive Optic Neuritis
por: Prabhakar, Appaswamy T., et al.
Publicado: (2021)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
por: Jurynczyk, Maciej, et al.
Publicado: (2017)

Seronegative and seropositive rheumatoid arthritis treated with rituximab
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012)

Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study
por: Oertel, Frederike C., et al.
Publicado: (2019)

Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis
por: Messina, Silvia, et al.
Publicado: (2021)

A case report of neurosyphilis coexisting with a positive MOG antibody manifested as optic neuritis
por: Shi, Min, et al.
Publicado: (2023)

New Onset Visual Loss in MOG Antibody Disease: Optic Neuritis or Central Serous Retinopathy?
por: James, Joe, et al.
Publicado: (2022)

Uveitis, optic neuritis and MOG
por: Gupta, Pranjal, et al.
Publicado: (2020)

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies
por: Yeo, Tianrong, et al.
Publicado: (2020)

Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody–Associated Diseases
por: Avouac, Alexandre, et al.
Publicado: (2021)

The neuromyelitis optica presentation and the aquaporin-4 antibody in HIV-seropositive and seronegative patients in KwaZulu-Natal, South Africa
por: Bhigjee, Ahmed I., et al.
Publicado: (2017)

Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers
por: Tré-Hardy, Marie, et al.
Publicado: (2021)

Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?
por: Stiebel-Kalish, Hadas, et al.
Publicado: (2019)

Electrophysiological studies in patients with seropositive/seronegative myasthenia gravis
por: Vahabi, Zahra, et al.
Publicado: (2021)

Therapy response in seronegative versus seropositive autoimmune encephalitis
por: Berger, Benjamin, et al.
Publicado: (2023)

Analysis of serum immune markers in seropositive and seronegative rheumatoid arthritis and in high-risk seropositive arthralgia patients
por: Chalan, Paulina, et al.
Publicado: (2016)

Antibody seropositivity and endemicity of chikungunya and Zika viruses in Nigeria
por: Mac, Peter Asaga, et al.
Publicado: (2023)

A multi-facet comparative analysis of neuromyelitis optica spectrum disorders in patients with seropositive and seronegative AQP4-IgG
por: Wang, Xiaojuan, et al.
Publicado: (2018)

Value of Area Postrema Syndrome in Differentiating Adults With AQP4 vs. MOG Antibodies
por: Hyun, Jae-Won, et al.
Publicado: (2020)

Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity
por: Duan, Tianjiao, et al.
Publicado: (2019)

Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV‐16/18 antibodies
por: Rosillon, Dominique, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p6c5ckfb71n9khcroapfids7sb